Literature DB >> 20236628

Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.

Deborah M Brown1.   

Abstract

CD4 T cells have traditionally been regarded as helpers and regulators of adaptive immune responses; however, a novel role for CD4 T cells as direct mediators of protection against viral infections has emerged. CD4 T cells with cytolytic potential have been described for almost 40 years, but their role in host protection against infectious disease is only beginning to be realized. In this review, we describe the current literature identifying these cells in patients with various infections, mouse models of viral infection and our own work investigating the development of cytolytic CD4 cells in vivo and in vitro. CD4 CTL are no longer considered an artefact of cell culture and may play a physiological role in viral infections such as EBV, CMV, HIV and influenza. Therefore, vaccine strategies aimed at targeting CD4 CTL should be developed in conjunction with vaccines incorporating B cell and CD8 CTL epitopes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236628      PMCID: PMC2874968          DOI: 10.1016/j.cellimm.2010.02.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  62 in total

1.  West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.

Authors:  James D Brien; Jennifer L Uhrlaub; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection.

Authors:  Kathleen A Stuller; Emilio Flaño
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

Review 3.  CD4 T cells: fates, functions, and faults.

Authors:  Jinfang Zhu; William E Paul
Journal:  Blood       Date:  2008-09-01       Impact factor: 22.113

4.  Characterization of effector functions of human peptide-specific CD4+ T-cell clones for an intracellular pathogen.

Authors:  Peter Klucar; Peter F Barnes; Ying Kong; Buka Samten; Amy Tvinnereim; Ralf Spallek; Gerald T Nepom; Mahavir Singh; Homayoun Shams
Journal:  Hum Immunol       Date:  2008-06-25       Impact factor: 2.850

5.  CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.

Authors:  D H Canaday; R J Wilkinson; Q Li; C V Harding; R F Silver; W H Boom
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.

Authors:  Tracey A Haigh; Xiaorong Lin; Hui Jia; Edwin P Hui; Anthony T C Chan; Alan B Rickinson; Graham S Taylor
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 7.  Cytotoxic human CD4(+) T cells.

Authors:  Pablo J van de Berg; Ester M van Leeuwen; Ineke J ten Berge; Rene van Lier
Journal:  Curr Opin Immunol       Date:  2008-04-24       Impact factor: 7.486

8.  Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Arnob Banerjee; Naofumi Takemoto; Scott M Gordon; Caitlin S Dejong; Haina Shin; Christopher A Hunter; E John Wherry; Tullia Lindsten; Steven L Reiner
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

9.  Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers.

Authors:  J Zhang; I Scordi; M J Smyth; M G Lichtenheld
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.

Authors:  Fernando Cruz-Guilloty; Matthew E Pipkin; Ivana M Djuretic; Ditsa Levanon; Joseph Lotem; Mathias G Lichtenheld; Yoram Groner; Anjana Rao
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  70 in total

1.  Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection.

Authors:  Min Fang; Nicholas A Siciliano; Adam R Hersperger; Felicia Roscoe; Angela Hu; Xueying Ma; Ahamed R Shamsedeen; Laurence C Eisenlohr; Luis J Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

Review 2.  CD4 T-cell immunotherapy for chronic viral infections and cancer.

Authors:  Alice O Kamphorst; Rafi Ahmed
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

3.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.

Authors:  Lei Bao; Morton J Cowan; Kimberly Dunham; Biljana Horn; Joseph McGuirk; Andrew Gilman; Kenneth G Lucas
Journal:  J Immunother       Date:  2012-04       Impact factor: 4.456

5.  MHC class II tetramer analyses in AE37-vaccinated prostate cancer patients reveal vaccine-specific polyfunctional and long-lasting CD4(+) T-cells.

Authors:  Eleftheria A Anastasopoulou; Ioannis F Voutsas; Michael Papamichail; Constantin N Baxevanis; Sonia A Perez
Journal:  Oncoimmunology       Date:  2016-05-02       Impact factor: 8.110

6.  Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.

Authors:  Stephen R Goding; Kyle A Wilson; Ying Xie; Kristina M Harris; Aparna Baxi; Akgul Akpinarli; Amy Fulton; Koji Tamada; Scott E Strome; Paul Andrew Antony
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

7.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.

Authors:  Simone Kayser; Cristina Boβ; Judith Feucht; Kai-Erik Witte; Alexander Scheu; Hans-Jörg Bülow; Stefanie Joachim; Stefan Stevanović; Michael Schumm; Susanne M Rittig; Peter Lang; Martin Röcken; Rupert Handgretinger; Tobias Feuchtinger
Journal:  Oncoimmunology       Date:  2015-05-21       Impact factor: 8.110

9.  HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

Authors:  Jacob Couturier; Alexander T Hutchison; Miguel A Medina; Cosmina Gingaras; Petri Urvil; Xiaoying Yu; Chi Nguyen; Parag Mahale; Lin Lin; Claudia A Kozinetz; Joern E Schmitz; Jason T Kimata; Tor C Savidge; Dorothy E Lewis
Journal:  Virology       Date:  2014-07-04       Impact factor: 3.616

10.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.